Drug intelligence / Profile preview

Restylane Lip Volume

Development stage: Unknown
Lead developer: Galderma
Administration: Intradermal

Overview

Restylane Lip Volume is a sterile, biodegradable, transparent gel of non-animal cross-linked hyaluronic acid with the addition of 0.3% lidocaine hydrochloride. It is a dermal filler specifically designed for lip augmentation and the correction of lip contours. The product was originally part of the Emervel range (as Emervel Lips) before being rebranded under the Restylane portfolio by Galderma. It utilizes Optimal Balance Technology (OBT) to create a smooth gel texture that integrates into the soft tissue of the lips, providing volume while allowing for natural facial expressions. The inclusion of lidocaine serves to reduce pain during and after the injection procedure.

Brand names: Restylane Lip VolumeEmervel Lips
Other names: Restylane Lip Volume with Lidocaine

Beyond the preview

Go deeper on Restylane Lip Volume.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Restylane Lip Volume.

Explore the full profile